XML 43 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes the stock option activity during the three months ended March 31, 2025:
Stock
Option
Shares
Weighted Average
Exercise
Price
Weighted Average
Remaining
Contractual
Term (in Years)
Aggregate
Intrinsic
Value (in thousands)
Outstanding, December 31, 20244,950,016 $10.82 7.99$1,818 
Granted687,979 2.31 
Exercised(22,204)0.95 
Cancelled/Forfeited(288,972)11.52 
Outstanding as of March 31, 20255,326,819 $9.72 8.06$29 
Options exercisable as of March 31, 20252,996,934 $13.26 7.41$— 
Vested and expected to vest as of March 31, 20255,326,819 $9.72 8.06$29 
Schedule of Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
Activity with respect to the Company’s restricted stock units during the three months ended March 31, 2025 is as follows:
SharesWeighted Average
Grant Date Fair Value
Nonvested shares at December 31, 2024256,490 $1.92 
Granted— — 
Vested/Issued(63,250)1.92 
Forfeited(31,519)1.92 
Nonvested shares at March 31, 2025161,721 $1.92 
Schedule of Recognized Compensation Cost Related to Employee and Non-employee Stock-Based Compensation Activity
The Company recognized the following compensation cost related to employee and non-employee share-based compensation activity for the periods presented (in thousands):
Three Months Ended March 31,
20252024
Selling, general and administrative$983 $2,342 
Research and development697 1,247 
Total$1,680 $3,589 
Schedule of Stock Options Valuation Assumptions
The calculation was based on the following assumptions:
Three Months Ended March 31,
20252024
Weighted average grant date fair value (per share)$1.76$1.43
Risk-free interest rate
4.02% - 4.02%
4.13% - 4.14%
Expected volatility
89.48% - 89.48%
89.22% - 91.46%
Expected term (in years)
6.1 - 6.1
5.0 - 6.1
Expected dividend yield